Sirnaomics 過去の業績
過去 基準チェック /06
Sirnaomics's earnings have been declining at an average annual rate of -2.7%, while the Biotechs industry saw earnings growing at 31.7% annually. Revenues have been growing at an average rate of 37.9% per year.
主要情報
-2.7%
収益成長率
30.3%
EPS成長率
| Biotechs 業界の成長 | 11.0% |
| 収益成長率 | 37.9% |
| 株主資本利益率 | n/a |
| ネット・マージン | -7,587.8% |
| 前回の決算情報 | 30 Jun 2024 |
最近の業績更新
Recent updates
収支内訳
Sirnaomics の稼ぎ方とお金の使い方。LTMベースの直近の報告された収益に基づく。
収益と収入の歴史
| 日付 | 収益 | 収益 | G+A経費 | 研究開発費 |
|---|---|---|---|---|
| 30 Jun 24 | 1 | -82 | 23 | 38 |
| 31 Mar 24 | 1 | -80 | 23 | 46 |
| 31 Dec 23 | 0 | -79 | 23 | 54 |
| 30 Sep 23 | 0 | -82 | 24 | 60 |
| 30 Jun 23 | 0 | -84 | 24 | 66 |
| 31 Mar 23 | 0 | -86 | 24 | 67 |
| 31 Dec 22 | 1 | -88 | 24 | 68 |
| 30 Sep 22 | 1 | -230 | 25 | 69 |
| 30 Jun 22 | 1 | -223 | 22 | 60 |
| 31 Mar 22 | 0 | -218 | 19 | 51 |
| 31 Dec 21 | 0 | -213 | 16 | 41 |
| 30 Sep 21 | 0 | -60 | 10 | 27 |
| 31 Dec 20 | 0 | -44 | 5 | 15 |
| 31 Dec 19 | 0 | -16 | 5 | 10 |
質の高い収益: 2257 is currently unprofitable.
利益率の向上: 2257 is currently unprofitable.
フリー・キャッシュフローと収益の比較
過去の収益成長分析
収益動向: 2257 is unprofitable, and losses have increased over the past 5 years at a rate of 2.7% per year.
成長の加速: Unable to compare 2257's earnings growth over the past year to its 5-year average as it is currently unprofitable
収益対業界: 2257 is unprofitable, making it difficult to compare its past year earnings growth to the Biotechs industry (5.5%).
株主資本利益率
高いROE: 2257's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.